Jill Johnson adminsters the Pfizer COVID-19 vaccine to Sharee Livingston, an OB-GYN with UPMC Lititz.
The Centers for Disease Control (CDC) reports that in the U.S. 10.2 million people have received the first dose of the Pfizer or Moderna vaccine.
Plan to apply for an Emergency Use Authorization (EUA) in February with the U.S. FDA and file in other countries, too.
At the same time, it is premature to get into the specifics of the supply of our vaccine candidate, as we do not yet have Phase 3 data, nor have we filed for or been granted Emergency Use Authorization.
We remain in active discussions with regulators, including on the approval and validation of our manufacturing processes.
We have begun the production of our vaccine candidate and are confident in our ability to meet our 2021 supply commitments signed with governments, and we expect to share more detail after some of these steps are achieved.
- J&J's One-Shot COVID Vaccine Is Safe and Generates Promising Immune Response in Early TrialNBC Connecticut
- Johnson & Johnson hits snags, falls behind on coronavirus vaccine productionNew York Daily News
- Single-shot COVID-19 vaccine by J&J shows promising immune response in early trialWBAL Baltimore
- Johnson & Johnson coronavirus vaccine generates immune response, few side effects, in early trialsKRDO
- J&J COVID-19 vaccine on track for March rollout, still aims for 1 bln doses this year -execNasdaq
- Dollar General Is Offering Extra Pay to Workers Who Want to Get the COVID-19 VaccineYahoo Lifestyle
- EXPLAINER: Vaccine push gains steam but many still face waitKEPR 19
- Dollar General will pay its 157000 workers to get COVID-19 vaccineWGNO
- Johnson & Johnson's One-Dose COVID Vaccine Promising in Early TrialU.S. News & World Report
